Tripathi, Brajendra K. http://orcid.org/0000-0003-2841-8380
Anderman, Meghan F. http://orcid.org/0000-0002-6413-2745
Bhargava, Disha
Boccuzzi, Luciarita
Qian, Xiaolan
Wang, Dunrui
Durkin, Marian E. http://orcid.org/0000-0002-0005-8806
Papageorge, Alex G.
de Miguel, Fernando J.
Politi, Katerina
Walters, Kylie J. http://orcid.org/0000-0001-7590-2891
Doroshow, James H.
Lowy, Douglas R. http://orcid.org/0000-0003-0635-219X
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (Intramural Research Program of the Center for Cancer Research, National Cancer Institute)
Article History
Received: 8 February 2021
Accepted: 25 October 2021
First Online: 3 December 2021
Competing interests
: K. Politi is co-inventor on a patent licensed to Molecular MD for EGFR T790M mutation testing (through MSKCC). K. Politi has recently received Honoraria/Consulting fees from AstraZeneca and Halda and research support from AstraZeneca, Roche, Boehringer Ingelheim and D2G Oncology. The remaining authors declare no competing interests.